Latest Headlines

  1. Labware And Phizzle Partnership To Eliminate Manual Instrument Data Transfer In Pharmaceutical Cleanroom Labs 4/8/2026

    LabWare, a global provider of laboratory informatics, and Phizzle, an innovator in laboratory data integration, today announced a partnership to simplify how regulated laboratories connect environmental monitoring instruments and move instrument data into LabWare LIMS.

  2. Degasser For Volatile And Aggressive Chromatography Solvents 4/8/2026

    Biotech Fluidics announce the DEGASi Integration HFIP - a high-performance online system designed to efficiently degas even the toughest solvents. This unique degasser is fully compatible with a wide range of volatile and aggressive liquids including Hexafluoroisopropanol (HFIP) and silanes but can also manage all other solvents used for GPC/SEC and HPLC.

  3. Rune Labs Launches Parkinson's AI Companion Trained On The World's Largest Parkinson's Dataset 4/8/2026

    Today, Rune Labs announced the launch of a personalized AI companion to provide always-on support for people with Parkinson’s disease. Powered by Anthropic's Claude and built on Rune Labs' proprietary longitudinal dataset, comprising millions of hours of wearable data and FDA-cleared symptom algorithms, StrivePD Guardian continuously analyzes patients' real-time data to deliver timely, context-aware guidance on symptoms, medications, daily experiences, and care goals.

  4. Saladax Biomedical To Expand International Access To Drug Level Testing For Psychiatry And Oncology 4/7/2026

    Saladax Biomedical, Inc., a leader in therapeutic drug monitoring (TDM) diagnostics for psychiatry and oncology, today announced a distribution agreement with Thermo Fisher Scientiļ¬c to expand global access to high-quality TDM assays that support clinicians in optimizing patient outcomes.

  5. HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics 4/7/2026

    HNL Lab Medicine today announced a preferred partnership with Roche Diagnostics.

  6. PathAI And MedStar Health Announce Partnership To Deploy The AISight® Dx Digital Pathology Platform And Advanced AI Applications 4/7/2026

    PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced a multi-year strategic collaboration to deploy PathAI’s AISight® Dx1 Digital Pathology Platform and various AI algorithm products across the multi-site network.

  7. Plus Therapeutics Receives AMA PLA Code For CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement And U.S. Commercial Adoption 4/7/2026

    Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces that the American Medical Association (AMA) has approved a new, Proprietary Laboratory Analyses (PLA) Current Procedural Terminology (CPT) code for its CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) test.

  8. Unique Tube Technology Enhances Sample Management Workflows 4/7/2026

    Azenta Life Sciences reports how its unique Acoustic tube technology is enabling fully acoustic workflows promoting faster, more efficient sample management in next-generation compound management and screening workflows.

  9. UCLA Researchers Develop Low-Cost Blood Test To Detect Multiple Cancers And Other Diseases From A Single Sample 4/6/2026

    UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities simultaneously by analyzing DNA fragments circulating in the bloodstream.

  10. Blood Test Using Artificial Intelligence Paves The Way For Early Diagnosis Of Leprosy 4/6/2026

    A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. Researchers at the University of São Paulo (USP) tested the new test in Brazil using blood samples collected during a COVID-19 population survey.